SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-135027
Filing Date
2018-04-26
Accepted
2018-04-26 16:47:03
Documents
6
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d507558ddefa14a.htm DEFA14A 48964
2 GRAPHIC g507558dsp6.jpg GRAPHIC 1589
3 GRAPHIC g507558dsp7.jpg GRAPHIC 1381
4 GRAPHIC g507558dsp7a.jpg GRAPHIC 2044
5 GRAPHIC g507558dsp8.jpg GRAPHIC 1655
6 GRAPHIC g507558dsp9.jpg GRAPHIC 1691
  Complete submission text file 0001193125-18-135027.txt   62184
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36281 | Film No.: 18779290
SIC: 2834 Pharmaceutical Preparations